Neuburgh Advisers’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$124K Buy
6,868
+136
+2% +$2.25K ﹤0.01% 768
2019
Q2
$105K Buy
6,732
+1,156
+21% +$22.7K ﹤0.01% 798
2019
Q1
$127K Hold
5,576
﹤0.01% 752
2018
Q4
$130K Hold
5,576
0.01% 720
2018
Q3
$184K Buy
5,576
+2,176
+64% +$81.3K 0.01% 710
2018
Q2
$150K Hold
3,400
0.01% 717
2018
Q1
$142K Hold
3,400
0.01% 722
2017
Q4
$155K Buy
3,400
+442
+15% +$17.4K 0.01% 713
2017
Q3
$98K Buy
2,958
+136
+5% +$5.54K ﹤0.01% 758
2017
Q2
$115K Buy
2,822
+136
+5% +$4.21K ﹤0.01% 700
2017
Q1
$54K Buy
2,686
+272
+11% +$5.75K ﹤0.01% 747
2016
Q4
$56K Buy
+2,414
New +$51.7K ﹤0.01% 724

Other funds holding PETS

Neuburgh Advisers's PETS Position: Q3 2019 in Review

Neuburgh Advisers increased its PetMed Express (PETS) stake by 2% in Q3 2019, buying an estimated $2.25K and bringing the position to 6,868 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #768.

Neuburgh Advisers first reported a position in PETS in Q4 2016 and has held it in 12 quarters since. The position peaked at $184K in Q3 2018. 170 funds tracked by Wall St. Rank hold PETS as of Q3 2019.

  • Neuburgh Advisers held 6,868 shares of PetMed Express worth $124K as of Q3 2019.
  • Neuburgh Advisers bought 136 PetMed Express shares in Q3 2019, an estimated $2.25K.
  • PetMed Express made up ﹤0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #768 holding.
  • Neuburgh Advisers first reported a position in PetMed Express in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's PetMed Express position peaked at $184K in Q3 2018.
  • 170 funds tracked by Wall St. Rank held PetMed Express as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.